May 06, 2020 / 09:00PM GMT
Operator
Ladies and gentlemen, good afternoon. I would like to welcome everyone to the Theravance Biopharma conference call. (Operator Instructions) Today's conference call is being recorded.
And now I would like to turn the call over to Gail Cohen, Vice President, Corporate Communications and Investor Relations. Please go ahead.
Gail B. Cohen - Theravance Biopharma, Inc. - VP of Corporate Communications & IR
Good afternoon, everyone. And thank you for joining the Theravance Biopharma conference call and webcast to discuss our first quarter 2020 financial results and outlook. I hope everyone is safe and remaining healthy during this unprecedented time.
As always, I remind you that this conference call will contain forward-looking statements, which involve certain risks and uncertainties, including statements about our product pipeline, expected benefits of our products, the anticipated timing of trial results and regulatory filings and expected sales and financial results. Information concerning factors that could cause results to differ materially
Q1 2020 Theravance Biopharma Inc Earnings Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers